{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:52:00Z","timestamp":1774288320569,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd012814","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000}}],"reference-count":113,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012814.pub2","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T15:55:15Z","timestamp":1631548515000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma"],"prefix":"10.1002","volume":"2021","author":[{"given":"Vor","family":"Luvira","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine; Khon Kaen University; Khon Kaen Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egapong","family":"Satitkarnmanee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine; Khon Kaen University; Khon Kaen Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ake","family":"Pugkhem","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine; Khon Kaen University; Khon Kaen Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chumnan","family":"Kietpeerakool","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Medicine; Khon Kaen University; Khon Kaen Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pisake","family":"Lumbiganon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Medicine; Khon Kaen University; Khon Kaen Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Porjai","family":"Pattanittum","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Faculty of Public Health; Khon Kaen University; Khon Kaen Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD012814.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bjs.10776","article-title":"Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer","volume":"105","author":"Ebata","year":"2018","journal-title":"British Journal of Surgery"},{"issue":"8","key":"10.1002\/14651858.CD012814.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/SLA.0000000000002865","article-title":"A prospective, randomized phase ii study of adjuvant gemcitabine versus s-1 after major hepatectomy for biliary tract cancer (KHBO 1208): Kansai Hepato-Biliary Oncology Group","volume":"270","author":"Kobayashi","year":"2019","journal-title":"Annals of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD012814.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncology"},{"issue":"8","key":"10.1002\/14651858.CD012814.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD012814.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1200\/jco.2011.29.4_suppl.299","article-title":"Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma","volume":"29","author":"Di Girolamo","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD012814.pub2-BIB0007|cit7","first-page":"L22","article-title":"Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs)","volume":"26","author":"Ghidini","year":"2015","journal-title":"Annals of Oncology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012814.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"S1133","DOI":"10.1245\/s10434-015-4599-8","article-title":"Adjuvant chemotherapy and radiation therapy is associated with improved survival for patients with extrahepatic cholangiocarcinoma","volume":"22","author":"Hoehn","year":"2015","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00280-016-3206-4","article-title":"The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas","volume":"79","author":"Kim","year":"2017","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012814.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jso.24836","article-title":"Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: a multi-institution analysis from the U.S. Extrahepatic Biliary Malignancy Consortium","volume":"117","author":"Krasnick","year":"2018","journal-title":"Journal of Surgical Oncology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/1471-2407-9-345","article-title":"Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study","volume":"9","author":"Lim","year":"2009","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00595-016-1354-0","article-title":"Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis","volume":"47","author":"Mizuno","year":"2017","journal-title":"Surgery Today"},{"issue":"5","key":"10.1002\/14651858.CD012814.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1245\/s10434-018-6388-7","article-title":"Adjuvant therapy is associated with improved survival in resected perihilar cholangiocarcinoma: a propensity matched study","volume":"25","author":"Nassour","year":"2018","journal-title":"Annals of Surgical Oncology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0014|cit14","unstructured":"Clinical trial of adjuvant chemotherapy followed by concurrent chemoradiotherapy compared with adjuvant chemotherapy alone in patients with gallbladder carcinoma and extrahepatic cholangiocarcinoma clinicaltrials.gov\/ct2\/show\/NCT02798510"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0015|cit15","unstructured":"A study of cisplatin or carboplatin with gemcitabine versus gemcitabine alone as adjuvant therapy in patients with resected or ablation intra-hepatic cholangiocarcinoma clinicaltrials.gov\/ct2\/show\/NCT03081039"},{"issue":"12","key":"10.1002\/14651858.CD012814.pub2-BIB0016|cit16","first-page":"7049","article-title":"Characterization of prognostic factors and the efficacy of adjuvant s-1 chemotherapy in patients with post-surgery extrahepatic bile duct cancer","volume":"37","author":"Okabayashi","year":"2017","journal-title":"Anticancer Research"},{"issue":"7","key":"10.1002\/14651858.CD012814.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00432-017-2392-8","article-title":"The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis","volume":"143","author":"Schweitzer","year":"2017","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12885-017-3967-0","article-title":"Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: a prospective single center phase II study","volume":"18","author":"Siebenhuner","year":"2018","journal-title":"BMC Cancer"},{"issue":"15 Suppl","key":"10.1002\/14651858.CD012814.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"e15170","DOI":"10.1200\/jco.2015.33.15_suppl.e15170","article-title":"Adjuvant chemotherapy using S-1 improves survival in patients with resected advanced extra-hepatic bile duct cancer: a propensity score matching analysis","volume":"33","author":"Toyoki","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD012814.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2017.35.4_suppl.330","article-title":"A phase II study of gemcitabine as adjuvant treatment for biliary tract cancer after surgical resection","volume":"35","author":"Woo","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012814.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/jjco\/hyy004","article-title":"A randomized phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)","volume":"48","author":"Nakachi","year":"2018","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0022|cit22","unstructured":"Oxaliplatin+gemcitabine vs capecitabine as adjuvant therapy for intrahepatic cholangiocarcinoma clinicaltrials.gov\/ct2\/show\/NCT02548195"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0023|cit23","unstructured":"Adjuvant capecitabine vs gemcitabine plus cisplatin in resected extrahepatic cholangiocarcinoma clinicaltrials.gov\/ct2\/show\/NCT03079427"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0024|cit24","unstructured":"A study to investigate apatinib combined capecitabine on adjuvant therapy of biliary carcinoma clinicaltrials.gov\/ct2\/show\/NCT03609489"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-015-1498-0","article-title":"Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial","volume":"15","author":"Stein","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0026|cit26","unstructured":"A randomized controlled trial of gemcitabine alone versus gemcitabine plus cisplatin as an adjuvant chemotherapy after curative intent resection of cholangiocarcinoma www.thaiclinicaltrials.org\/show\/TCTR20161101003"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0027|cit27","first-page":"97","article-title":"Detection of circulating tumor cells in cancers of biliary origin","volume":"3","author":"Al Ustwani","year":"2012","journal-title":"Journal of Gastrointestinal Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012814.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"102975","DOI":"10.1016\/j.critrevonc.2020.102975","article-title":"Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials","volume":"151","author":"Belkouz","year":"2020","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","article-title":"Epidemiology of cholangiocarcinoma","volume":"29","author":"Bergquist","year":"2015","journal-title":"Best Practice & Research. Clinical Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012814.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive - Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD012814.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011430","article-title":"Adjuvant chemotherapy for resected early-stage non-small cell lung cancer","author":"Burdett","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012814.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00003495-198631040-00004","article-title":"Adjuvant chemotherapy of cancer. A review of its current status","volume":"31","author":"Carter","year":"1986","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0036|cit36","unstructured":"Veritas Health Innovation Covidence 2020"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0038|cit38","unstructured":"EndNote Version X7 Thomas Reuters 2015"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0039|cit39","unstructured":"FACIT Group Functional assessment of cancer therapy - Hepatobiliary cancers (FACT-Hep) www.facit.org\/measures\/FACT-Hep"},{"issue":"3","key":"10.1002\/14651858.CD012814.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005390.pub2","article-title":"Adjuvant therapy for completely resected stage II colon cancer","author":"Figueredo","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012814.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.hpb.2017.05.010","article-title":"Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis","volume":"19","author":"Ghidini","year":"2017","journal-title":"HPB: the Official Journal of the International Hepato-Pancreato-Biliary Association"},{"issue":"6","key":"10.1002\/14651858.CD012814.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.annonc.a010676","article-title":"Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer","volume":"7","author":"Glimelius","year":"1996","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0043|cit43","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"4","key":"10.1002\/14651858.CD012814.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012814.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012814.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012814.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012814.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines: 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012814.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012814.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012814.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles - continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD012814.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 15. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jclinepi.2017.05.005","article-title":"GRADE guidelines: 17. Assessing the risk of bias associated with missing participant outcome data in a body of evidence","volume":"87","author":"Guyatt","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7414","key":"10.1002\/14651858.CD012814.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0058|cit58","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"16","key":"10.1002\/14651858.CD012814.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD012814.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.surg.2012.12.005","article-title":"Recurrence after operative management of intrahepatic cholangiocarcinoma","volume":"153","author":"Hyder","year":"2013","journal-title":"Surgery"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0061|cit61","volume-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"6","key":"10.1002\/14651858.CD012814.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0002-9610(01)00628-6","article-title":"Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma","volume":"181","author":"Isa","year":"2001","journal-title":"American Journal of Surgery"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"e0004293","DOI":"10.1371\/journal.pntd.0004293","article-title":"A comprehensive public health conceptual framework and strategy to effectively combat cholangiocarcinoma in Thailand","volume":"10","author":"Khuntikeo","year":"2016","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"11","key":"10.1002\/14651858.CD012814.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD012814.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004706.pub5","article-title":"Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer","author":"Lawrie","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7314\/APJCP.2016.17.1.401","article-title":"Cholangiocarcinoma patient outcome in northeastern Thailand: single-center prospective study","volume":"17","author":"Luvira","year":"2016","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/jgh.13481","article-title":"Long-term outcome of surgical resection for intraductal papillary neoplasm of the bile duct","volume":"32","author":"Luvira","year":"2017","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012814.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"802","DOI":"10.5604\/01.3001.0012.3140","article-title":"Association between repeated praziquantel treatment and papillary, and intrahepatic cholangiocarcinoma","volume":"17","author":"Luvira","year":"2018","journal-title":"Annals of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012814.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e14013","DOI":"10.1097\/MD.0000000000014013","article-title":"Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: a meta-analysis","volume":"98","author":"Ma","year":"2019","journal-title":"Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012814.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41416-020-0987-3","article-title":"Current and novel therapeutic opportunities for systemic therapy in biliary cancer","volume":"123","author":"Marin","year":"2020","journal-title":"British Journal of Cancer"},{"issue":"11","key":"10.1002\/14651858.CD012814.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1536867X1301300106","article-title":"Trial sequential boundaries for cumulative meta-analysis","volume":"13","author":"Miladinovic","year":"2013","journal-title":"Stata Journal"},{"issue":"9128","key":"10.1002\/14651858.CD012814.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD012814.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jclinepi.2013.02.004","article-title":"The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses","volume":"66","author":"Mustafa","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections","volume":"258","author":"Nagino","year":"2013","journal-title":"Annals of Surgery"},{"issue":"4","key":"10.1002\/14651858.CD012814.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0078|cit78","unstructured":"National Comprehensive Cancer Network Clinical practice guidelines in oncology: hepatobiliary cancers version 4, 2019 www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0079|cit79","unstructured":"Capecitabine or observation after surgery in treating patients with biliary tract cancer clinicaltrials.gov\/ct2\/show\/NCT00363584"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0080|cit80","unstructured":"Gemcitabine hydrochloride and oxaliplatin or observation in treating patients with biliary tract cancer that has been removed by surgery clinicaltrials.gov\/ct2\/show\/NCT01313377"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0081|cit81","unstructured":"Phase II study of gemcitabine versus S-1 adjuvant therapy after hemihepatectomy for biliary tract cancer clinicaltrials.gov\/ct2\/show\/NCT01815307"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0082|cit82","unstructured":"Parkin DM Whelan SL Ferlay J Teppo L Thomas DB Cancer incidence in five continents, vol. VIII, 2002 publications.iarc.fr\/Book-And-Report-Series\/Iarc-Scientific-Publications\/Cancer-Incidence-In-Five-Continents-Volume-VIII-2002"},{"issue":"24","key":"10.1002\/14651858.CD012814.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7314\/APJCP.2013.14.1.321","article-title":"Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand","volume":"14","author":"Pattanathien","year":"2013","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"3","key":"10.1002\/14651858.CD012814.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004078.pub2","article-title":"Postoperative adjuvant chemotherapy in rectal cancer operated for cure","author":"Petersen","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00000441-198707000-00005","article-title":"Adjuvant chemotherapy of solid tumors","volume":"294","author":"Powell","year":"1987","journal-title":"American Journal of the Medical Sciences"},{"issue":"4 Pt A","key":"10.1002\/14651858.CD012814.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejso.2019.11.499","article-title":"Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: a systematic review and meta-analysis","volume":"46","author":"Rangarajan","year":"2020","journal-title":"European Journal of Surgical Oncology"},{"issue":"9935","key":"10.1002\/14651858.CD012814.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0089|cit89","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2020"},{"issue":"35","key":"10.1002\/14651858.CD012814.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD012814.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012814.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD012814.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD012814.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOG.0b013e3282fbf9b3","article-title":"Cholangiocarcinoma: lessons from Thailand","volume":"24","author":"Sripa","year":"2008","journal-title":"Current Opinion in Gastroenterology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomized controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD012814.pub2-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069.pub2","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012814.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"ii93","DOI":"10.1093\/annonc\/mdi712","article-title":"The role of chemotherapy in cholangiocarcinoma","volume":"16","author":"Thongprasert","year":"2005","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0099|cit99","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0100|cit100","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User Manual for Trial Sequential Analysis (TSA); 2nd edition. Copenhagen Trial Unit, 2017 Available from ctu.dk\/tsa\/learn-more"},{"issue":"12","key":"10.1002\/14651858.CD012814.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4251\/wjgo.v7.i12.503","article-title":"Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand","volume":"7","author":"Titapun","year":"2015","journal-title":"World Journal of Gastrointestinal Oncology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0102|cit102","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2017"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0103|cit103","unstructured":"Randomised phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resectable bile duct cancer upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000000983"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.hbpd.2018.11.001","article-title":"The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: a meta-analysis and systematic review","volume":"18","author":"Wang","year":"2019","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"issue":"4","key":"10.1002\/14651858.CD012814.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1072-7515(01)01016-X","article-title":"Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes","volume":"193","author":"Weber","year":"2001","journal-title":"Journal of the American College of Surgeons"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD012814.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD012814.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD012814.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"154-7","DOI":"10.1007\/s005340170039","article-title":"Recurrence after surgical resection of intrahepatic cholangiocarcinoma","volume":"8","author":"Yamamoto","year":"2001","journal-title":"Journal of Hepato-Biliary-Pancreatic Surgery"},{"issue":"6","key":"10.1002\/14651858.CD012814.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3892\/mco.2014.377","article-title":"Survival outcomes and prognostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: adjuvant therapy is a favorable prognostic factor","volume":"2","author":"Yang","year":"2014","journal-title":"Molecular and Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD012814.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/apt.12900","article-title":"Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer","volume":"40","author":"Zhu","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD012814.pub2-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012814","article-title":"Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma","author":"Luvira","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T12:20:25Z","timestamp":1678278025000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012814.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":113,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012814.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]}}}